BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36066699)

  • 1. Neuroblastoma SH-SY5Y Cell Differentiation to Mature Neuron by AM580 Treatment.
    Cai A; Lin Z; Liu N; Li X; Wang J; Wu Y; Gao K; Jiang Y
    Neurochem Res; 2022 Dec; 47(12):3723-3732. PubMed ID: 36066699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Effects of Acitretin on Human Neuronal SH-SY5Y Cells.
    Cai A; Liu N; Lin Z; Li X; Wang J; Wu Y; Gao K; Jiang Y
    Neurochem Res; 2023 Jan; 48(1):72-81. PubMed ID: 35987975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR; Hu LS; Li GY
    Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic Profiling Discloses Molecular and Cellular Events Related to Neuronal Differentiation in SH-SY5Y Neuroblastoma Cells.
    Pezzini F; Bettinetti L; Di Leva F; Bianchi M; Zoratti E; Carrozzo R; Santorelli FM; Delledonne M; Lalowski M; Simonati A
    Cell Mol Neurobiol; 2017 May; 37(4):665-682. PubMed ID: 27422411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secretome of adipose-derived mesenchymal stem cells protects SH-SY5Y cells from arsenic-induced toxicity, independent of a neuron-like differentiation mechanism.
    Curtis TM; Hannett JM; Harman RM; Puoplo NA; Van de Walle GR
    Neurotoxicology; 2018 Jul; 67():54-64. PubMed ID: 29660375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating SH-SY5Y Neuroblastoma Cell Surfaceome as a Model for Neuronal-Targeted Novel Therapeutic Modalities.
    Gangras P; Gelfanova V; Williams GD; Handelman SK; Smith RM; Debets MF
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and sub-cellular Cu isotope fractionation in the human neuroblastoma SH-SY5Y cell line: proliferating versus neuron-like cells.
    Costas-Rodríguez M; Colina-Vegas L; Solovyev N; De Wever O; Vanhaecke F
    Anal Bioanal Chem; 2019 Jul; 411(19):4963-4971. PubMed ID: 31093701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different concentrations of adapalene induce differentiation and apoptosis of SH-SY5Y cells].
    Liu NN; Zhang JJ; Zhang F; Wu CY; Jiang YW
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):282-288. PubMed ID: 38557381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway.
    Choi J; Hwang J; Ramalingam M; Jeong HS; Jang S
    BMC Neurosci; 2023 May; 24(1):28. PubMed ID: 37127577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of human neuroblastoma cell line SH-SY5Y with HSP27 siRNA tagged-exosomes decreased differentiation rate into mature neurons.
    Shokrollahi E; Nourazarian A; Rahbarghazi R; Salimi L; Karbasforush S; Khaksar M; Salarinasab S; Abhari A; Heidarzadeh M
    J Cell Physiol; 2019 Nov; 234(11):21005-21013. PubMed ID: 31012118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
    Kovalevich J; Santerre M; Langford D
    Methods Mol Biol; 2021; 2311():9-23. PubMed ID: 34033074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation Induces Dramatic Changes in miRNA Profile, Where Loss of Dicer Diverts Differentiating SH-SY5Y Cells Toward Senescence.
    Jauhari A; Singh T; Pandey A; Singh P; Singh N; Srivastava AK; Pant AB; Parmar D; Yadav S
    Mol Neurobiol; 2017 Sep; 54(7):4986-4995. PubMed ID: 27525675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degree of differentiation impacts neurobiological signature and resistance to hypoxia of SH-SY5Y cells.
    Voogd EJHF; Doorn N; Levers MR; Hofmeijer J; Frega M
    J Neural Eng; 2024 Jan; 20(6):. PubMed ID: 38128130
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach.
    Magalingam KB; Somanath SD; Ramdas P; Haleagrahara N; Radhakrishnan AK
    J Mol Neurosci; 2022 May; 72(5):1026-1046. PubMed ID: 35258800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.
    Shipley MM; Mangold CA; Kuny CV; Szpara ML
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel APP splice variant-dependent marker system to precisely demarcate maturity in SH-SY5Y cell-derived neurons.
    Kulatunga DCM; Ranaraja U; Kim EY; Kim RE; Kim DE; Ji KB; Kim MK
    Sci Rep; 2024 May; 14(1):12113. PubMed ID: 38802572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOP2B Is Required to Maintain the Adrenergic Neural Phenotype and for ATRA-Induced Differentiation of SH-SY5Y Neuroblastoma Cells.
    Khazeem MM; Casement JW; Schlossmacher G; Kenneth NS; Sumbung NK; Chan JYT; McGow JF; Cowell IG; Austin CA
    Mol Neurobiol; 2022 Oct; 59(10):5987-6008. PubMed ID: 35831557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
    Lim J; Choi HS; Choi HJ
    J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the Chr16p11.2 ASD candidate gene
    Haslinger D; Waltes R; Yousaf A; Lindlar S; Schneider I; Lim CK; Tsai MM; Garvalov BK; Acker-Palmer A; Krezdorn N; Rotter B; Acker T; Guillemin GJ; Fulda S; Freitag CM; Chiocchetti AG
    Mol Autism; 2018; 9():56. PubMed ID: 30443311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells.
    Murata H; Tajima N; Nagashima Y; Yao M; Baba M; Goto M; Kawamoto S; Yamamoto I; Okuda K; Kanno H
    Cancer Res; 2002 Dec; 62(23):7004-11. PubMed ID: 12460920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.